LifeStance Health Group, Inc. (LFST) financial statements and ratios from SEC XBRL: revenue $1.6B (TTM), net margin 0.7%, revenue growth 26.1% YoY, P/E 92.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.42B |
| Revenue (TTM) | $1.6B |
| Net Margin | 0.7% |
| Operating Margin (TTM) | 4.9% |
| Net Debt / EBITDA | 0.4 |
| Revenue Growth (YoY) | 26.1% |
| FCF Growth (YoY) | 55.2% |
| P/E Ratio | 92.7 |
| EV / EBITDA | 39.2 |
| Price / Book | 3.18 |
| Price / Sales | 2.96 |
| FCF Yield | 3.7% |
| Altman Z-Score | 4.46 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
LFST overview · LFST earnings · LFST KPIs · LFST documents · LFST ownership · LFST peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.